Skip to main content

7 Result(s)

within T Lutz Remove this filter Public Health Remove this filter

and

  1. Article

    Open Access

    Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort

    J van Lunzen, G Fätkenheuer, T Lutz, S Klauke… in Journal of the International AIDS Society (2010)

    Download PDF (156 KB) View Article

  2. Article

    Open Access

    0314. Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort

    A Baumgarten, T Lutz, P Kreckel, E Wellmann… in Journal of the International AIDS Society (2010)

    Download PDF (620 KB) View Article

  3. Article

    Open Access

    Once-daily saquinavir (SAQ)/ritonavir (RTV) (2000/100 mg) with abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/300 mg) in naïve patients

    M Bickel, A Bodtlaender, G Knecht, M Kurowski… in Journal of the International AIDS Society (2008)

    Download PDF (516 KB) View Article

  4. Article

    Open Access

    The Rainbow Cohort: saquinavir/r is effective and well tolerated in antiretroviral therapy (ART)-naïve patients – 48-week results from Germany

    H Knechten, C Stephan, T Lutz, A Stoehr… in Journal of the International AIDS Society (2008)

    Download PDF (266 KB) View Article

  5. Article

    Open Access

    Antiretroviral tolerability and efficacy after switch to saquinavir in PI-experienced patients: 48-week analysis of the German Rainbow Cohort

    C Stephan, H Jaeger, A Carganico, G Knecht… in Journal of the International AIDS Society (2008)

    Download PDF (463 KB) View Article

  6. Article

    Open Access

    Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitors

    A Wendig, C Stephan, P Khaykin, M Bickel… in Journal of the International AIDS Society (2008)

    Download PDF (566 KB) View Article

  7. Article

    Open Access

    Efficacy and safety of TDF/FTC-containing first-line HAART in clinical practice – 2-year data from the German Outpatient Cohort

    J van Lunzen, G Fätkenheuer, T Lutz, S Klauke… in Journal of the International AIDS Society (2008)

    Download PDF (143 KB) View Article